🇯🇵 日本語 🇺🇸 English
3,817 companies 12,975 AI summaries 9,784 risk analyses 5,404 growth scores Register free — watchlist & alerts →
EDINET 3088 Positive Risk Analyzed 📈 Growth 6/10

MatsukiyoCocokara & Co

Semi-Annual Report - 20th Term(2026/04/01 - 2027/03/31) ／ 2026-11-13 16:30

Covers EDINET statutory filings (TDNET timely disclosures / earnings flashes are not included).

EarningsM&ADividend UpM&A/AllianceNew ProductNew MarketCapacity
AI Summary 2026-11-13 16:41

H1 FY2026 showed solid revenue +5.2% (¥549.1B → ¥577.5B) and OP +3.3%, while pursuing M&A strategy (acquiring Universal Drug and John Masters Organics) under the "Alliance Construct" initiative. Domestic store network expanded to 3,686 units.

KEY POINTS
  • Revenue +5.2%, PAT +7.8% to ¥285.8B, demonstrating double-digit earnings growth
  • M&A execution: acquired Universal Drug and John Masters Organics Holdings to realize 'Alliance Construct' strategy
  • Expanded to 3,686 domestic stores (incl. 1,122 pharmacies) and 114 overseas stores; interim dividend of ¥28.00/share declared
📊 Revenue
Revenue +5.2% (¥549.1B → ¥577.5B)
💰 Operating profit
OP +3.3% (¥404.4B → ¥417.6B)
🔮 Outlook
FY2027E: Revenue +3.4%, OP +3.0%, NI +5.8%
📈 Growth outlook 📈 Growth 6/10
Mid-term initiatives (FY2031 target) focus on differentiation strategy, investment in platform infrastructure, and ASEAN/overseas expansion. M&A-driven store network consolidation and digital transformation support moderate growth trajectory.
Growth drivers
  • Store network expansion via M&A (Universal Drug, John Masters Organics acquisitions)
  • Strength in pharmacy co-location and urban-focused store development strategy
  • Private brand growth (matsukiyo 10th anniversary, new 'Pixcella' premium skincare line)
  • ASEAN-led international business expansion (114 overseas stores)
Risk and growth scores and tags are AI-generated estimates from analyzing the disclosure. They are not guarantees of fact, nor investment advice or recommendations. Make investment decisions at your own discretion.
⚠️ Extracted Risk Factors
CategoryDescriptionScoreNew
Intensified Competition Risk Retail industry facing intensified competition from new drugstore openings, M&A-driven consolidation by rivals, and encroachment by non-traditional competitors, leading to compressed catchment areas. 7/10
M&A Risk John Masters Organics and other recent M&A targets present goodwill impairment risk (¥54.2B goodwill arising, allocation incomplete) and execution risk on synergy realization timelines. 6/10
Market Risk Prolonged geopolitical risks (Middle East tensions, financial market volatility) may dampen domestic economic recovery and consumer spending sentiment. 5/10
Foreign Exchange Risk Increasing overseas exposure (Thailand, Taiwan, Vietnam, Hong Kong with 114 stores) exposes consolidated results to FX volatility. 4/10 NEW
Supply Chain Risk Scaling eco-friendly PB products and sustainable supply chains across expanded store network requires significant operational coordination and supplier investment. 4/10 NEW
7/10 Intensified Competition Risk
Retail industry facing intensified competition from new drugstore openings, M&A-driven consolidation by rivals, and encroachment by non-traditional competitors, leading to compressed catchment areas.
6/10 M&A Risk
John Masters Organics and other recent M&A targets present goodwill impairment risk (¥54.2B goodwill arising, allocation incomplete) and execution risk on synergy realization timelines.
5/10 Market Risk
Prolonged geopolitical risks (Middle East tensions, financial market volatility) may dampen domestic economic recovery and consumer spending sentiment.
4/10 NEW Foreign Exchange Risk
Increasing overseas exposure (Thailand, Taiwan, Vietnam, Hong Kong with 114 stores) exposes consolidated results to FX volatility.
4/10 NEW Supply Chain Risk
Scaling eco-friendly PB products and sustainable supply chains across expanded store network requires significant operational coordination and supplier investment.
X LinkedIn Threads Bluesky Facebook
Track Japanese disclosures with JSIGNAL

AI summaries, risk & growth analysis, watchlist alerts and a screener for every Japanese listed company.

Start free — 30-day trial Login